Back to News
Market Impact: 0.25
UTMD's Q3 Earnings Rise Y/Y on Lower Costs, Orion Acquisition
Source: zacks.com
Corporate EarningsCompany FundamentalsCorporate Guidance & Outlook
Utah Medical's Q3 earnings per share rose 7% year over year despite revenue declining 12.1%, as lower operating expenses supported earnings. Management expects the revenue decline to be smaller for full-year 2026.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
0.10
More News
- What investors need to know about Alphabet's stock-busting earnings report
- Our next steps for Alphabet stock after earnings disappoint at nearly every turn
- SK Hynix says the memory-chip shortage will last until 2030—and more than half its production is booked for the next two years
- China’s tech darlings are losing their shine. Here’s what’s behind the sell-off
- GE Vernova shares slip despite a beat-and-raise. What the sellers are getting wrong
- Asian shares fall as Alphabet earnings miss drags Wall St futures lower